Targeted polypeptide degradation
Patent
·
OSTI ID:983006
- Brookline, MA
This invention pertains to compositions, methods, cells and organisms useful for selectively localizing polypeptides to the proteasome for degradation. Therapeutic methods and pharmaceutical compositions for treating disorders associated with the expression and/or activity of a polypeptide by targeting these polypeptides for degradation, as well as methods for targeting therapeutic polypeptides for degradation and/or activating therapeutic polypeptides by degradation are provided. The invention provides methods for identifying compounds that mediate proteasome localization and/or polypeptide degradation. The invention also provides research tools for the study of protein function.
- Research Organization:
- Harvard University
- Sponsoring Organization:
- USDOE
- DOE Contract Number:
- FG02-87ER60565
- Assignee:
- President and Fellows of Harvard College (Cambridge, MA)
- Patent Number(s):
- 7,371,539
- Application Number:
- 11/003,103
- OSTI ID:
- 983006
- Country of Publication:
- United States
- Language:
- English
Similar Records
The induction of heme oxygenase-1 suppresses heat shock protein 90 and the proliferation of human breast cancer cells through its byproduct carbon monoxide
Endothelial monocyte activating polypeptide-II modulates endothelial cell responses by degrading hypoxia-inducible factor-1alpha through interaction with PSMA7, a component of the proteasome
SIRT1 inhibits proliferation of pancreatic cancer cells expressing pancreatic adenocarcinoma up-regulated factor (PAUF), a novel oncogene, by suppression of {beta}-catenin
Journal Article
·
Wed Jan 01 00:00:00 EST 2014
· Toxicology and Applied Pharmacology
·
OSTI ID:983006
+4 more
Endothelial monocyte activating polypeptide-II modulates endothelial cell responses by degrading hypoxia-inducible factor-1alpha through interaction with PSMA7, a component of the proteasome
Journal Article
·
Wed Jul 01 00:00:00 EDT 2009
· Experimental Cell Research
·
OSTI ID:983006
+2 more
SIRT1 inhibits proliferation of pancreatic cancer cells expressing pancreatic adenocarcinoma up-regulated factor (PAUF), a novel oncogene, by suppression of {beta}-catenin
Journal Article
·
Fri Jun 29 00:00:00 EDT 2012
· Biochemical and Biophysical Research Communications
·
OSTI ID:983006
+6 more